Company intelligence / Profile preview

Black Hills Cardiovascular Research

Rapid City, South Dakota, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~5
Development stage: Phase 3

Overview

Currently enrolling in at least one Phase III randomized placebo-controlled trial evaluating ferric carboxymaltose for the treatment of heart failure with iron deficiency[3]. The broader institution participates in over 20 cardiovascular clinical trials and has an established record in advanced heart failure research[5][6]. Recognized regionally and nationally for quality cardiovascular care and research programs[5][6].

Therapeutic areas: Cardiovascular
Modalities: Small moleculeBiologic
Industry: Academic Hospital/University/Research

Partnerships

Collaborates closely within Monument Health system; no major external pharma/biotech partnerships listed.

Beyond the preview

Go deeper on Black Hills Cardiovascular Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Black Hills Cardiovascular Research.

Explore the full profile